comparemela.com
Latest Breaking News On - Biostar pharma inc - Page 1 : comparemela.com
UTD1 Receives FDA Orphan Drug Designation in Breast Cancer Brain Metastasis
Utidelone injectable has received FDA orphan drug designation for patients with breast cancer brain metastases.
Biostar-pharma
Biostar-pharma-inc
Response-assessment
Fda
Breast-cancer-brain-metastases
Fda-orphan-drug-designation
Utidelone-injectable
73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis
SAN FRANCISCO, March 29, 2024 /PRNewswire/ Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic
Thailand
Biostar-pharma
Biostar-pharma-inc
Biostar-pharmaceuticals-co-ltd
Orphan-drug-designation
Thailand-business
FDA Grants ODD to Utidelone Capsules For Treatment of Gastric Cancer
The orphan drug designation is a result of positive findings from a phase 2 clinical trial which demonstrated a 100% clinical benefit rate in patients.
Biostar-pharma-utidelone
Biostar-pharma
Li-tang
Sebastian-kaulitzki
Biostar-pharma-inc
Hanmi-pharmaceuticals
Kinex-pharmaceuticals
Biostar-pharmaceuticals
Utidelone-capsule
Patients-with-advanced-solid
Odonate-therapeutics
FDA Approved Utidelone Injectable (UTD1) Phase 2/3 Multi-National Clinical Trial for Non-Small Cell Lung Cancer
/PRNewswire/ Biostar Pharma, Inc. (hereinafter referred to as "Biostar"), the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a.
United-states
Li-tang
Guangdong
China
American
Chinese
Dumontetc-chemoresistance
Biostar-pharma
Promotion-association-for
Oncology-branch-of-chinese-international-exchange
European-lung-cancer-congress
American-cancer-society
vimarsana © 2020. All Rights Reserved.